Verse uses synthetic data generation, stress testing, and reinforcement learning to train AI voice and text agents on ...

The AI-driven rare disease patient finder market is poised for strong growth, driven by genomic sequencing, EHR utilization, ...

Detailed price information for Tango Therapeutics Inc (TNGX-Q) from The Globe and Mail including charting and trades.

Details for the Company’s ASH abstracts and oral presentation can be found here: Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the ...

From silver nanofibers to smart, sensory-packed dressings, the next generation of wound-healing technology is blurring the ...

Following the FDA approval of a vagus nerve stimulator for rheumatoid arthritis, supporters of the device’s use have lauded ...

The global biotechnology market is expected to grow at a rate of 13-15% over the next five years. Key drivers of this growth ...

Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of ...

Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient Enrollment of FT819, an ...

The world is quickly learning about topics once confined to the dorkier corners of identity, as deepfake tech reshapes ...

The peptides being promoted by influencers, celebrities and wellness gurus are different: Many have never been approved for ...